MarketCap
Facebook
X
Telegram
Kinnate Biopharma EV | KNTE
EV Jährlich Kinnate Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81.2 M | 198 M | 236 M | -132 M | 95.1 M | 467 K | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 236 M | -132 M | 79.7 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Cerevel Therapeutics Holdings
CERE
|
6.84 B | - | - | $ 7.29 B |  USA |
 |
NexImmune
NEXI
|
5.52 M | - | 70.13 % | $ 4.12 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
2.11 B | $ 3.23 | -0.16 % | $ 545 M |  Singapore |
 |
Theravance Biopharma
TBPH
|
574 M | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
Xenetic Biosciences
XBIO
|
-2.54 M | $ 1.72 | 3.78 % | $ 2.93 M | USA |
|
XBiotech
XBIT
|
-45.4 M | $ 1.82 | -5.7 % | $ 55.5 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
2.24 B | $ 35.76 | 1.19 % | $ 2.83 B |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
1.23 B | $ 10.21 | 0.05 % | $ 1.64 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
66 M | $ 3.26 | 0.46 % | $ 138 M | USA |
 |
IMV
IMV
|
23.6 M | - | - | $ 13.1 M | Canada |
 |
22nd Century Group
XXII
|
1.92 M | $ 0.09 | -54.43 % | $ 16.6 K | USA |
 |
Karuna Therapeutics
KRTX
|
11.7 B | - | - | $ 12.2 B | USA |
 |
Chimerix
CMRX
|
-6.72 M | - | - | $ 756 M | USA |
 |
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | USA |
 |
LogicBio Therapeutics
LOGC
|
53.4 M | - | - | $ 229 M | USA |
 |
Zai Lab Limited
ZLAB
|
21.4 B | $ 24.36 | 1.35 % | $ 26.7 B |  China |
|
89bio
ETNB
|
928 M | - | - | $ 1.55 B | USA |
 |
Zentalis Pharmaceuticals
ZNTL
|
229 M | $ 2.06 | -6.79 % | $ 148 M | USA |
 |
Zymeworks
ZYME
|
783 M | $ 28.38 | 0.57 % | $ 1.46 B | Canada |
 |
Fusion Pharmaceuticals
FUSN
|
1.39 B | - | - | $ 1.41 B | Canada |
 |
Gritstone Oncology
GRTS
|
339 M | - | 0.42 % | $ 213 M | USA |
 |
Harpoon Therapeutics
HARP
|
38.3 M | - | - | $ 763 M | USA |
 |
HOOKIPA Pharma
HOOK
|
-8.35 M | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
-2.59 M | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
102 M | - | - | $ 109 M | USA |
 |
Akouos
AKUS
|
107 M | - | 0.23 % | $ 488 M | USA |
 |
Otonomy
OTIC
|
90.8 M | - | -1.96 % | $ 4.68 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | USA |
 |
Seagen
SGEN
|
26 B | - | - | $ 42.2 B | USA |
 |
Baudax Bio
BXRX
|
29.8 M | - | 0.59 % | $ 63 K | USA |
 |
ChemoCentryx
CCXI
|
91.4 M | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
661 M | - | - | $ 789 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
57 M | - | 7.23 % | $ 2.72 M | USA |
 |
Oncternal Therapeutics
ONCT
|
27.3 M | - | -24.12 % | $ 1.56 M | USA |
 |
Iterum Therapeutics
ITRM
|
52.5 M | - | - | $ 591 K |  Irlanda |
 |
Spectrum Pharmaceuticals
SPPI
|
158 M | - | - | $ 189 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
4.35 M | - | - | $ 26.5 M | USA |
 |
Alpine Immune Sciences
ALPN
|
7.99 M | - | - | $ 2.17 B | USA |
 |
Concert Pharmaceuticals
CNCE
|
15.7 M | - | - | $ 401 M | USA |
 |
ImmunoGen
IMGN
|
935 M | - | - | $ 7.92 B | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
-6.87 M | - | -8.77 % | $ 12.4 M |  Israel |
 |
C4 Therapeutics
CCCC
|
262 M | $ 2.98 | -2.78 % | $ 247 M | USA |
 |
Histogen
HSTO
|
-3.2 M | - | 31.6 % | $ 2.12 M | USA |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |
 |
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | USA |
 |
Clovis Oncology
CLVS
|
870 M | - | -7.23 % | $ 13 M | USA |
 |
Kaleido Biosciences
KLDO
|
74.7 M | - | -3.69 % | $ 12.4 M | USA |
 |
VBI Vaccines
VBIV
|
-14 M | - | -50.87 % | $ 1.09 M | USA |
 |
Certara
CERT
|
1.38 B | $ 10.61 | 2.66 % | $ 1.7 B | USA |
 |
CTI BioPharma Corp.
CTIC
|
664 M | - | - | $ 1.2 B | USA |